Correlation Between Savara and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Savara and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Ikena Oncology, you can compare the effects of market volatilities on Savara and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Ikena Oncology.
Diversification Opportunities for Savara and Ikena Oncology
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Savara and Ikena is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Savara i.e., Savara and Ikena Oncology go up and down completely randomly.
Pair Corralation between Savara and Ikena Oncology
Given the investment horizon of 90 days Savara Inc is expected to under-perform the Ikena Oncology. In addition to that, Savara is 1.01 times more volatile than Ikena Oncology. It trades about 0.0 of its total potential returns per unit of risk. Ikena Oncology is currently generating about 0.02 per unit of volatility. If you would invest 175.00 in Ikena Oncology on September 2, 2024 and sell it today you would lose (2.00) from holding Ikena Oncology or give up 1.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Savara Inc vs. Ikena Oncology
Performance |
| Timeline |
| Savara Inc |
| Ikena Oncology |
Savara and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Savara and Ikena Oncology
The main advantage of trading using opposite Savara and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Savara vs. Stoke Therapeutics | Savara vs. Edgewise Therapeutics | Savara vs. Crinetics Pharmaceuticals | Savara vs. Dyne Therapeutics |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |